Thiol/disulfide exchange is required for membrane fusion directed by the Newcastle disease virus fusion protein.
Newcastle disease virus (NDV), an avian paramyxovirus, initiates infection with attachment of the viral hemagglutinin-neuraminidase (HN) protein to sialic acid-containing receptors, followed by fusion of viral and cell membranes, which is mediated by the fusion (F) protein. Like all class 1 viral fusion proteins, the paramyxovirus F protein is thought to undergo dramatic conformational changes upon activation. How the F protein accomplishes extensive conformational rearrangements is unclear. Since several viral fusion proteins undergo disulfide bond rearrangement during entry, we asked if similar rearrangements occur in NDV proteins during entry. We found that inhibitors of cell surface thiol/disulfide isomerase activity--5'5-dithio-bis(2-nitrobenzoic acid) (DTNB), bacitracin, and anti-protein disulfide isomerase antibody--inhibited cell-cell fusion and virus entry but had no effect on cell viability, glycoprotein surface expression, or HN protein attachment or neuraminidase activities. These inhibitors altered the conformation of surface-expressed F protein, as detected by conformation-sensitive antibodies. Using biotin maleimide (MPB), a reagent that binds to free thiols, free thiols were detected on surface-expressed F protein, but not HN protein. The inhibitors DTNB and bacitracin blocked the detection of these free thiols. Furthermore, MPB binding inhibited cell-cell fusion. Taken together, our results suggest that one or several disulfide bonds in cell surface F protein are reduced by the protein disulfide isomerase family of isomerases and that F protein exists as a mixture of oxidized and reduced forms. In the presence of HN protein, only the reduced form may proceed to refold into additional intermediates, leading to the fusion of membranes.
Jain
Surbhi
S
Department of Molecular Genetics and Microbiology, University of Massachusetts Medical School, 55 Lake Avenue North, Worcester, MA 01655, USA.
McGinnes
Lori W
LW
Morrison
Trudy G
TG
D000818:Animals; D001414:Bacitracin / Q000494:pharmacology; D019556:COS Cells; D002522:Chlorocebus aethiops; D004220:Disulfides / Q000737:chemistry; D004228:Dithionitrobenzoic Acid / Q000494:pharmacology; D004791:Enzyme Inhibitors / Q000494:pharmacology; D015707:HN Protein / Q000737:chemistry / Q000235:genetics / Q000502:physiology; D008561:Membrane Fusion / Q000187:drug effects / Q000502:physiology*; D008954:Models, Biological; D009522:Newcastle disease virus / Q000235:genetics / Q000472:pathogenicity* / Q000502:physiology*; D019704:Protein Disulfide-Isomerases / Q000037:antagonists & inhibitors / Q000378:metabolism; D011994:Recombinant Proteins / Q000737:chemistry / Q000235:genetics / Q000378:metabolism; D013438:Sulfhydryl Compounds / Q000737:chemistry; D014760:Viral Fusion Proteins / Q000737:chemistry / Q000235:genetics / Q000502:physiology*; D053585:Virus Attachment / Q000187:drug effects
D004220:Disulfides; D004791:Enzyme Inhibitors; D015707:HN Protein; D011994:Recombinant Proteins; D013438:Sulfhydryl Compounds; D014760:Viral Fusion Proteins; D001414:Bacitracin; D004228:Dithionitrobenzoic Acid; D019704:Protein Disulfide-Isomerases